Menu
Recruiting NCT06189859

Electrosurgical Modes for Endoscopic Submucosal Dissection in Peroral Endoscopic Esophageal Myotomy

Phase III Interventional Achalasia Achalasia Cardia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: endoscopic submucosal dissection using SPRAY COAG mode, endoscopic submucosal dissection using Precisect mode.
Who it may be relevant to
Registry conditions: Achalasia, Achalasia Cardia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Electrosurgical Modes for Endoscopic Submucosal Dissection in Peroral Endoscopic Esophageal Myotomy: a Randomized Controlled Trial

Overview

Peroral endoscopic esophagel myotomy (POEM) is a third space endoscopy technique that depends on creating a submucosal tunnel to expose the esophageal muscle and eventually perform an esophageal myotomy. Submucosal dissection can be performed using numerous electrosurgical modes. Spray coagulation has been anecdotally favored by many endoscopists due to its high coagulation power and assumed safety. Recently, Precisect mode has been developed, it has theoretical advantages of very minimal tissue penetration and minimal to no charring effect. In this trial, the investigators compare the efficacy and safety of both electrosurgical modes in POEM procedures.

Interventions

  • Procedure endoscopic submucosal dissection using SPRAY COAG mode
    After initial mucosal incision, submucosal dissection will be performed down to 2cm below the cardia using Spray coag mode using ERBE VIO3 generator and a Hybrid knife (T-type) aided by ERBEJET for submucosal injection
  • Procedure endoscopic submucosal dissection using Precisect mode
    After initial mucosal incision, submucosal dissection will be performed down to 2cm below the cardia using Precisect mode using ERBE VIO3 generator and a Hybrid knife (T-type) aided by ERBEJET for submucosal injection

Primary outcome measures

  • Speed of endoscopic submucosal dissection [Time frame: during the procedure]
Secondary outcome measures (5)
  • Intraprocedural Bleeding [Time frame: during the procedure]
  • Significant Intraprocedural bleeding [Time frame: during the procedure]
  • Other Adverse events [Time frame: during the procedure]
  • Total procedure duration [Time frame: during the procedure]
  • Endoscopic submucosal tunneling duration [Time frame: during the procedure]

Eligibility criteria

Inclusion criteria

  • Patients undergoing POEM procedure for any esophageal motility disorder
  • Esophageal motility disorder confirmed by high-resolution manometry and gastroscopy

Exclusion criteria

  • Esophageal varices
  • Esophageal neoplasms
  • Non-correctable coagulopathy
  • Failure to provide an informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Cairo

Identifiers

NCT: NCT06189859 · ESRCT

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗